DTL
PMVP icon

Dynamic Technology Lab’s PMV Pharmaceuticals PMVP Stock Holding History

Dynamic Technology Lab’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,185
Closed -$92K – 1333
2023
Q1 		$92K Sell
19,185
-5,684
-23% -$40K 0.01% 978
2022
Q4 		$216K Buy
+24,869
New +$265K 0.02% 889

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dynamic Technology Lab's PMVP Position: Q2 2023 in Review

Dynamic Technology Lab sold out of PMV Pharmaceuticals (PMVP) in Q2 2023, closing a stake of 19,185 shares — an estimated $92K sold.

Dynamic Technology Lab first reported a position in PMVP in Q4 2022 and held it in 2 quarters. The position peaked at $216K in Q4 2022. 106 funds tracked by Wall St. Rank hold PMVP as of Q2 2023.

  • Dynamic Technology Lab reported no remaining PMV Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 19,185 PMV Pharmaceuticals shares in Q2 2023, an estimated $92K.
  • Dynamic Technology Lab first reported a position in PMV Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Dynamic Technology Lab's PMV Pharmaceuticals position peaked at $216K in Q4 2022.
  • 106 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.